No photo of Julie Olson
Contact Expert

View Scopus Profile

Julie Olson

19972021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 4 Similar Profiles
Theilovirus Medicine & Life Sciences
Demyelinating Diseases Medicine & Life Sciences
Microglia Medicine & Life Sciences
Molecular Mimicry Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Multiple Sclerosis Medicine & Life Sciences
Epitopes Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2021

Ocular Hyperalgesia in Dry Eye

Bereiter, D. A. & Olson, J.

National Institutes of Health

9/30/17 → 4/30/21

Project: Research project

eyes

Microglia Activation in Neuropathic Pain during MS: Poss

Olson, J.

U.S. DEPARTMENT OF DEFENSE

4/1/17 → 3/31/20

Project: Research project

Microglia
Neuralgia
Therapeutics

Role of purinergic signaling and glia in TMJ nociception

Bereiter, D. A. & Olson, J.

NIH NIDCR NATL INST OF DENTAL

8/1/17 → 7/31/19

Project: Research project

Nociception
Temporomandibular Joint
Neuroglia

Trigeminal-autonomic Relations in Ocular Homeostasis

Bereiter, D. A. & Olson, J.

NIH NEI NATL EYE INST

9/30/15 → 9/29/17

Project: Research project

Research Output 1997 2019

  • 26 Article
  • 6 Review article
  • 1 Chapter
  • 1 Conference contribution

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

Khasabova, I., Khasabov, S., Olson, J., Uhelski, M. L., Kim, A. H., Albino-Ramírez, A. M., Wagner, C. L., Seybold, V. S. & Simone, D. A., Mar 1 2019, In : Pain. 160, 3, p. 688-701 14 p.

Research output: Contribution to journal › Article

pioglitazone
Peroxisome Proliferator-Activated Receptors
Neuralgia
Cisplatin
Oxidative Stress
3 Citations (Scopus)

Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease

Cataldo, G., Lunzer, M. M., Olson, J., Akgun, E., Belcher, J. D., Vercellotti, G. M., Portoghese, P. S. & Simone, D. A., Jul 1 2018, In : Pain. 159, 7, p. 1382-1391 10 p.

Research output: Contribution to journal › Article

Open Access
Nociception
Sickle Cell Anemia
Ligands
Pain
Morphine
29 Citations (Scopus)

Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism

Boontanrart, M., Hall, S. D., Spanier, J. A., Hayes, C. E. & Olson, J., Mar 15 2016, In : Journal of Neuroimmunology. 292, p. 126-136 11 p.

Research output: Contribution to journal › Article

Cholecalciferol
Microglia
Interleukin-10
Cytokines
Down-Regulation
3 Citations (Scopus)

Effect of the innate immune response on development of Theiler’s murine encephalomyelitis virus-induced demyelinating disease

Olson, J., Oct 21 2014, In : Journal of neurovirology. 20, 5, p. 427-436 10 p.

Research output: Contribution to journal › Article

Theilovirus
Demyelinating Diseases
Innate Immunity
Virus Diseases
Central Nervous System
10 Citations (Scopus)

IFNγ influences type i interferon response and susceptibility to Theiler's virus-induced demyelinating disease

Bowen, J. L. & Olson, J. K., Aug 1 2013, In : Viral Immunology. 26, 4, p. 223-238 16 p.

Research output: Contribution to journal › Review article

Theilovirus
Demyelinating Diseases
Interferons
Innate Immunity
Interferon Type I